Kristy Grimm

Patient-Reported Outcomes in Virologically Suppressed, HIV-1–Infected Subjects After Switching to a Simplified, Single-Tablet Regimen of Efavirenz, Emtricitabine, and Tenofovir DF

Sally Hodder, Karam Mounzer, Edwin DeJesus et al. · AIDS Patient Care and STDs · 2010 · 82 citations

Factors Associated with Complete Adherence to HIV Combination Antiretroviral Therapy

Timothy Juday, Shaloo Gupta, Kristy Grimm et al. · HIV Clinical Trials · 2011 · 57 citations

Randomization to Once-Daily Stavudine Extended Release/Lamivudine/Efavirenz Versus a More Frequent Regimen Improves Adherence While Maintaining Viral Suppression

Brian A Boyle, Dushyantha Jayaweera, Mallory D. Witt et al. · HIV Clinical Trials · 2008 · 45 citations · Full text

A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States

Timothy Juday, Kristy Grimm, Annette Zoe-Powers et al. · AIDS Care · 2011 · 39 citations · Full text

Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological failure in virologically suppressed patients

Rafael Campo, C Cohen, Kristy Grimm et al. · International Journal of STD & AIDS · 2010 · 26 citations